167 related articles for article (PubMed ID: 20819499)
21. [Chronic obstructive pulmonary disease in inhabitants of Zabrze].
Niepsuj G; Kozielski J; Niepsuj K; Ziora D; Polońska A; Cieślicki J; Rauer R; Dworniczak S; Kamiński J; Jastrzebski D; Krzywiecki A; Gabryś J; Oklek K
Wiad Lek; 2002; 55 Suppl 1():354-9. PubMed ID: 15002268
[TBL] [Abstract][Full Text] [Related]
22. Preselection of patients at risk for COPD by two simple screening questions.
Kögler H; Metzdorf N; Glaab T; Welte T
Respir Med; 2010 Jul; 104(7):1012-9. PubMed ID: 20138491
[TBL] [Abstract][Full Text] [Related]
23. The prevalence of chronic obstructive pulmonary disease in Elazig, Eastern Turkey.
Deveci F; Deveci SE; Türkoğlu S; Turgut T; Kirkil G; Rahman S; Açik Y; Muz MH
Eur J Intern Med; 2011 Apr; 22(2):172-6. PubMed ID: 21402248
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of chronic obstructive pulmonary disease screening in a high risk population].
Zhang RB; He QY; Tan XY; Yang RH; Li XL
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jan; 32(1):17-20. PubMed ID: 19484956
[TBL] [Abstract][Full Text] [Related]
25. Is COPD a rare disease? Prevalence and identification rates in smokers aged 40 years and over within general practice in Germany.
Gingter C; Wilm S; Abholz HH
Fam Pract; 2009 Feb; 26(1):3-9. PubMed ID: 19033180
[TBL] [Abstract][Full Text] [Related]
26. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative.
Buist AS; Vollmer WM; McBurnie MA
Int J Tuberc Lung Dis; 2008 Jul; 12(7):703-8. PubMed ID: 18544191
[TBL] [Abstract][Full Text] [Related]
27. The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea.
Kim SJ; Suk MH; Choi HM; Kimm KC; Jung KH; Lee SY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
Int J Tuberc Lung Dis; 2006 Dec; 10(12):1393-8. PubMed ID: 17167958
[TBL] [Abstract][Full Text] [Related]
28. Poor sensitivity of symptoms in early detection of COPD.
Akamatsu K; Yamagata T; Kida Y; Tanaka H; Ueda H; Ichinose M
COPD; 2008 Oct; 5(5):269-73. PubMed ID: 18972274
[TBL] [Abstract][Full Text] [Related]
29. [Prevalence of COPD in Iceland--the BOLD study].
Benediktsdóttir B; Gudmundsson G; Jörundsdóttir KB; Vollmer W; Gíslason T
Laeknabladid; 2007 Jun; 93(6):471-7. PubMed ID: 17541146
[TBL] [Abstract][Full Text] [Related]
30. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
[TBL] [Abstract][Full Text] [Related]
31. Better understanding the influence of cigarette smoking and indoor air pollution on chronic obstructive pulmonary disease: a case-control study in Mainland China.
Xu F; Yin X; Shen H; Xu Y; Ware RS; Owen N
Respirology; 2007 Nov; 12(6):891-7. PubMed ID: 17986120
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers.
Miravitlles M; Ferrer M; Pont A; Luis Viejo J; Fernando Masa J; Gabriel R; Jiménez-Ruiz CA; Villasante C; Fernández-Fau L; Sobradillo V
Respir Med; 2005 Aug; 99(8):985-95. PubMed ID: 15950139
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of COPD in Abu Dhabi, United Arab Emirates.
Al Zaabi A; Asad F; Abdou J; Al Musaabi H; Al Saiari MB; Buhussien AS; Nagelkerke N; Soriano JB
Respir Med; 2011 Apr; 105(4):566-70. PubMed ID: 21216136
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC.
Fukahori S; Matsuse H; Takamura N; Hirose H; Tsuchida T; Kawano T; Fukushima C; Mizuta Y; Kohno S
Int J Clin Pract; 2009 Feb; 63(2):269-74. PubMed ID: 19196365
[TBL] [Abstract][Full Text] [Related]
35. [The relationship between smoking and the incidence of COPD].
Cheng X; Li J; Zhang Z
Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):290-2. PubMed ID: 11775857
[TBL] [Abstract][Full Text] [Related]
36. Population-based study on the prevalence of spirometric obstructive pattern in Porto, Portugal.
Mascarenhas J; Falcão H; Lourenço P; Paulo C; Patacho M; Bettencourt P; Azevedo A
Respir Care; 2011 May; 56(5):619-25. PubMed ID: 21276282
[TBL] [Abstract][Full Text] [Related]
37. Examining web equivalence and risk factor sensitivity of the COPD population screener.
Beaumont JL; Victorson D; Su J; Baker CL; Wortman K; Shah H; Cella D
Value Health; 2011 Jun; 14(4):506-12. PubMed ID: 21669376
[TBL] [Abstract][Full Text] [Related]
38. The cost-effectiveness of a questionnaire as a screening test for chronic obstructive pulmonary disease among the Bangkok elderly.
Maranetra N; Chuaychoo B; Lertakyamanee J; Naruman C; Chierakul N; Dejsomritrutai W; Nana A; Thamlikitkul W; Suthamsmai T; Saengkaew S; Sreelum W; Aksornin M; Dechapol A; Reungcham C
J Med Assoc Thai; 2003 Nov; 86(11):1033-41. PubMed ID: 14696785
[TBL] [Abstract][Full Text] [Related]
39. Norwegian population surveys on respiratory health in adults: objectives, design, methods, quality controls and response rates.
Gulsvik A; Humerfelt S; Bakke PS; Omenaas ER; Lehmann S
Clin Respir J; 2008 Oct; 2 Suppl 1():10-25. PubMed ID: 20298346
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities.
Miravitlles M; Soriano JB; García-Río F; Muñoz L; Duran-Tauleria E; Sanchez G; Sobradillo V; Ancochea J
Thorax; 2009 Oct; 64(10):863-8. PubMed ID: 19553233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
